| 廖冬颖,刘家宇,李悦,等.贾英杰辨治食管癌经验撷菁[J].浙江中医药大学学报,2024,48(2):170-173. |
| 贾英杰辨治食管癌经验撷菁 |
| JIA Yingjie’s Experience in the Diagnosis and Treatment of Esophageal Cancer |
| DOI：10.16466/j.issn1005-5509.2024.02.006 |
| 中文关键词: 食管癌 中医药 辨证论治 调气 名医经验 验案 贾英杰 |
| 英文关键词: esophageal cancer traditional Chinese medicine treatment based on pattern differentiation regulating Qi experience of renowned doctors proven cases JIA Yingjie |
| 基金项目:全国名中医传承工作室建设项目(974022)；国家自然科学基金项目(82104553) |
|
| 摘要点击次数: 1164 |
| 全文下载次数: 723 |
| 中文摘要: |
| [目的] 总结全国名中医贾英杰教授治疗食管癌的临床经验。[方法] 通过临证随诊，收集、分析贾教授对食管癌病因病机的认识及相关用药，并举验案一则加以佐证。[结果] 贾教授认为，食管癌病机可概括为，早期属“痰凝气滞”，晚期整体属“本元亏虚”，局部“痰瘀互结，气机阻膈”，痰、气、瘀胶结酿毒，变生癌浊，壅塞成瘤。临证辨治应始终以“气”为着眼点，尤重“气机”调达，肺、脾、肝三脏同调，根据患者的舌脉特点动态辨治，施药强调揆度“扶正”与“祛邪”的尺度，使瘀滞得化、癌毒得除、膈道得通。本文所附验案为正气亏虚，三焦代谢失常，以致癌浊久羁难化，辨证为痰凝气滞、瘀结阻膈证，治以降气化痰、化瘀宽中，根据患者病情变化，适时调整用药，终获良效。[结论] 贾教授基于食管癌的特点及患者的体质，辨病与辨证相结合治疗食管癌，为临床用药提供了一定的参考价值和新路径。 |
| 英文摘要: |
| [Objective] To summarize the clinical experience of Professor JIA Yingjie， a renowned traditional Chinese medicine practitioner in the treatment of esophageal cancer. [Methods] Through clinical following up， collect and analyze Professor JIA’s understanding of the etiology and pathogenesis of esophageal cancer and related medication， and a case of was attached as evidence. [Results] Professor JIA believes that the pathogenesis of esophageal cancer can be summarized as “phlegm coagulation and Qi stagnation” in the early stage， “primitive deficiency” in the late stage as a whole， “phlegm and blood stasis intermingle， Qi and blood stasis obstruct the diaphragm” in local areas， phlegm， Qi， and blood stasis solidify and poison transform into cancer turbidity， and block and form tumors. Clinical differentiation and treatment should always focus on “Qi”， with a particular emphasis on regulating the “Qi mechanism”. The lungs， spleen and liver are in sync， and dynamic differentiation and treatment should be carried out based on the characteristics of the patient’s tongue and pulse. Medication should emphasize the use of “strengthening the body resistance righting” and “dispelling pathogenic factors” to achieve the dissipation of blood stasis， the elimination of cancer toxins and the opening of the diaphragm. [Conclusion] Based on the characteristics of esophageal cancer and the patient’s physical constitution， Professor JIA combines disease and syndrome differentiation in treating esophageal cancer， providing a certain reference value and new path for clinical medication. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |